Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honey and Dexamethasone for Impacted Third Molar Surgery Complications
NCT04848259Phase 1Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Revamil in impacted third molar (I3M) (4 arms), sponsored by Al-Azhar University. Primary endpoints: Interincisal distance and Edema. Started Jan 2021; status: completed.
02
Drugs
Revamil
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT04848259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848259.